# Exercise Plus a GLP-1: What Each One Actually Changes

By Nora Bissett, Pricing Editor (https://glpwatchdog.org/authors/nora-bissett) | Published: 2026-08-19 | Updated: 2026-11-02

Canonical page: https://glpwatchdog.org/research/exercise-plus-glp1-what-changes

> In a four-arm randomized trial, the drug alone produced no improvement in physical fitness. Exercise did, with or without the drug, and the strength result needs reading carefully.

## Key points

- Physical fitness did not improve at all on the drug alone. It did on exercise alone.
- Combined vs drug alone: stair climb 8.6% faster, peak VO2 +3.0 mL/min/kg fat-free mass. Exercise alone did about as well.
- Relative strength rose because weight fell, not because muscle got stronger.
- Losing weight and doing neither cost 7.8% of relative strength.

A randomized trial split people who had lost weight by dieting into four groups: exercise, a GLP-1 drug, both, or neither. On physical fitness the answer was unambiguous and not the one the drug’s reputation implies. **The drug alone did not improve fitness at all.** Exercise did, with or without the drug.[1]

## What changed, and in whom

Compared with liraglutide alone, the combined group completed a stair-climb test 1.2 seconds faster (an 8.6% improvement) and improved peak oxygen consumption by 3.0 mL/min per kg of fat-free mass. Exercise alone produced similar benefits. Liraglutide alone produced none.[1]

The exercise was real: a median of 2.65 sessions a week, 116 minutes weekly, at 79% of maximum heart rate. That is structured training rather than walking more, and the trial found no significant difference in how much of it people did whether they were on the drug or on placebo. That answers a common worry about whether these drugs sap the capacity to train. Other training questions, from protein to planning workouts around injection day, are in [our exercise Q&A](https://glpwatchdog.org/research/qna/top-glp1-exercise-workout-questions-reddit-answered).

## The strength result, read carefully

Relative muscle strength (strength normalized to body weight) changed by −7.8% on placebo, −0.4% with exercise, +1.0% with liraglutide and +3.3% with both.[1] It is tempting to read the drug column as the drug making people stronger. It did not.

> Relative strength rose because weight fell and absolute strength held. The numerator did not improve; the denominator shrank.

The trial says exactly this: the improvement came from lower weight with preserved absolute strength. That is a good outcome, since carrying the same force through a lighter body is why stairs get easier, but it is not the same claim as building muscle. The distinction is the same one we drew in [muscle volume versus muscle function](https://glpwatchdog.org/research/muscle-volume-versus-muscle-function).

> **Look at the placebo column too.** Relative strength fell 7.8% in people who had lost weight by dieting and then did neither exercise nor drug. That is what unsupported weight loss does to functional capacity, and it is the baseline every other arm is being compared against.

## Why this trial is so useful

It is directly actionable, and the action is unglamorous. There is no supplement, no peptide, no dose adjustment. The finding is that the drug handles weight and exercise handles fitness, and that [they do not substitute for each other](https://glpwatchdog.org/research/lifestyle-plus-the-drug). Nor does a sauna substitute for either. Added to exercise in a randomized trial, it improved fitness and blood pressure but not fat loss (see [sauna and sweating for weight loss](https://glpwatchdog.org/research/sauna-and-sweating-for-weight-loss)). Metformin goes further the wrong way: in older adults it blunted the fitness and muscle gains from training, covered in [metformin vs a GLP-1 for longevity](https://glpwatchdog.org/research/metformin-vs-glp1-for-longevity).

- **If fitness matters to you, the drug will not deliver it.** Not at the dose tested, on this evidence.
- **Training on a GLP-1 is achievable.** Adherence in the drug arm matched the placebo arm at nearly three sessions a week.
- **Exercise beat the drug alone** on the functional measures people experience, and on its own it did about as well as the combination.
- **Doing neither, after weight loss, cost 7.8% of relative strength.** That is the price of the passive option.

## What it does not settle

The trial used **liraglutide**, a daily older drug, after diet-induced weight loss. Whether semaglutide or tirzepatide behave the same on fitness is untested here, and their larger weight effects could plausibly change the balance in either direction.

It also does not tell you what kind of training is best. Our [exercise pairing tool](https://glpwatchdog.org/tools/glp1-exercise-pairing-configurator) and the [strength training cheat sheet](https://glpwatchdog.org/research/cheat-sheets/glp1-exercise-strength-training-cheat-sheet) cover the practical side, and neither is contradicted by anything here.

## Frequently asked questions

### Do GLP-1 drugs improve fitness?

Not on their own. In a four-arm randomized trial, liraglutide alone produced no improvement in physical fitness, while exercise did, alone or combined with the drug. The combination gave an 8.6% faster stair climb and better peak oxygen consumption than the drug alone, and exercise alone did about as well.

### Can you train properly while taking one?

Yes. Participants on the drug completed a median 2.65 sessions a week at 79% of maximum heart rate, with no significant difference from those on placebo. Whatever the drug does to appetite, it did not reduce how much training people did.

### Did the drug make people stronger?

No. Relative strength rose 1.0% on the drug, but the trial attributes that to lower body weight with preserved absolute strength, meaning the same force through a lighter body. That is a real functional benefit and it is not muscle building.

### What happens if you lose weight and do neither?

Relative muscle strength fell 7.8% in that group. Weight loss without exercise or drug support cost functional capacity, which is the comparison every other arm in the trial is measured against.

### Does this apply to semaglutide or tirzepatide?

Untested here. The trial used liraglutide after diet-induced weight loss. The newer drugs produce larger weight changes, which could shift the balance either way, so this is a reasonable prior rather than a proven transfer.

## References

1. Jensen SBK, Fiorenza M, Juhl CR, et al. Physical Fitness with Exercise and GLP-1 Receptor Agonist Treatment Alone or Combined After Diet-Induced Weight Loss: A Secondary Analysis of a Randomized Controlled Trial in Adults with Obesity. Sports Medicine. 2026. PMID: 41579235. https://pubmed.ncbi.nlm.nih.gov/41579235/

---

Cite as: GLP Watchdog, Nora Bissett, "Exercise Plus a GLP-1: What Each One Actually Changes", published 2026-08-19, updated 2026-11-02. https://glpwatchdog.org/research/exercise-plus-glp1-what-changes

Canonical HTML page: https://glpwatchdog.org/research/exercise-plus-glp1-what-changes

Medical disclaimer: Nothing here is medical advice. We report on this subject; we do not treat anyone. Whether to begin a medication, supplement, or treatment, whether to adjust it, and whether to stop are questions for a clinician licensed to answer them, who knows your history.
